Israeli makes 'Scientific American''s top 50

By
November 8, 2006 17:52

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Dr. Shulamit Levenberg, a 37-year-old Technion biomedical engineer and tissue engineering researcher whose work aims toward the creation of lab-manufactured tissues and organs for transplant, has been included in Scientific American 50. The listing, selected by the prestigious science journal Scientific American, honors 50 people, teams, companies and organizations whose accomplishments in research, business or policymaking demonstrate technological leadership. Levenberg - modern Orthodox, married and the mother of five (including a baby) - hopes her work will eventually lead to the cure of degenerative diseases. save lives, stem cell researchers' work is encouraged. Although the construction of a whole synthetic pancreas, heart or lung is still far off, Levenberg and her colleagues are digging away at the problem bit by bit and believe an earlier achievement would be to repair damaged brain, cartilage or muscle tissue. At the Massachusetts Institute of Technology in Boston for five years of post-doctoral work, she built biological scaffolds to coax stem cells into developing into specific cell types. Understanding how they differentiate into different types of cells is a challenge and will supply a great deal of information on fetal development and the creation of blood vessels that nurture tissue, she says.

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia

By UNIVERSITY OF MICHIGAN HEALTH SYSTEM